Understanding the molecular basis of adaptive mechanisms resulting from loss of IP3R function may provide valuable insights into how cells can bypass the need for Ca2+ signaling and to predict the consequences of blocking IP3R function with drugs or in genetic diseases linked to IP3R dysfunction. This evidence concerns the gene ITPR1 and hereditary disease.